ClassID:

21647

A61K2300/00 - page 38 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#11101
20100226913
2010-09-09

Therapeutic compositions comprising monoterpenes

#11102
20100226910
2010-09-09

Tissue kallikrein for the treatment of diseases associated with amyloid protein

#11103
20100226906
2010-09-09

Recombinant poly-glutamic acid depolymerases

#11104
20100226904
2010-09-09

ORGANIC CHEWABLE SUPPLEMENT

#11105
20100226894
2010-09-09

Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood

#11106
20100226889
2010-09-09

HCV Combination Therapies

#11107
20100226888
2010-09-09

Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde

#11108
20100226887
2010-09-09

BETA-2-GLYCOPROTEIN 1 IS AN INHIBITOR OF ANGIOGENESIS

#11109
20100226886
2010-09-09

Combinations of MTP Inhibitors with Cholesterol Absorption Inhibitors or Interferon for Treating Hepatitis C

#11110
20100226885
2010-09-09

METHOD OF TREATING HEPATITIS C PATIENTS

#11111
20100226884
2010-09-09

Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)

#11112
20100226883
2010-09-09

Linked diimidazole derivatives

#11113
20100226882
2010-09-09

Linked diimidazole antivirals

#11114
20100226880
2010-09-09

TREATMENT WITH ANTI-VEGF ANTIBODIES

#11115
20100226873
2010-09-09

Hemostatic Composition with Magnetite

#11116
20100226866
2010-09-09

Solid preparation for oral application

#11117
20100222557
2010-09-02

Cytokine zalpha11 ligand antibodies

#11118
20100222438
2010-09-02

METHODS COMPOSITIONS AND ARTICLE OF MANUFACTURE FOR MODULATING BONE GROWTH

#11119
20100222418
2010-09-02

Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy

#11120
20100222410
2010-09-02

Nuclease compositions and methods

#11121
20100222390
2010-09-02

Methods and Compositions for the Intravenous Administration of Compounds Related to Proton Pump Inhibitors

#11122
20100222388
2010-09-02

Enhanced migraine treatments based on ghrelin mimetics

#11123
20100222375
2010-09-02

Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration

#11124
20100222360
2010-09-02

Treatment of Malignant Peripheral Nerve Sheath Tumors

#11125
20100222354
2010-09-02

AMPA Receptor Antagonists and Aldose Reductase Inhibitors for Neuropathic Pain

#11126
20100222327
2010-09-02

Methods of Preparing Pharmaceutical Compositions Comprising Eslicarbazepine Acetate and Methods of Use

#11127
20100222313
2010-09-02

Pharmaceutical compositions-4

#11128
20100222310
2010-09-02

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

#11129
20100222305
2010-09-02

COMPLEXES OF PHOSPHATE DERIVATIVES

#11130
20100222290
2010-09-02

Methods for concomitant administration of colchicine and macrolide antibiotics

#11131
20100222287
2010-09-02

Therapeutic Cancer Treatments

#11132
20100222275
2010-09-02

THERAPEUTIC AGENT FOR VITILIGO AND METHOD OF ACCELERATING PIGMENTATION

#11133
20100222271
2010-09-02

Formulation to improve gastrointestinal function

#11134
20100222259
2010-09-02

Compositions for enhancing the production of PPAR and/or PPAR-associated factors

#11135
20100222251
2010-09-02

MIXTURE COMPRISING AN AMYLIN PEPTIDE AND A PROTRACTED INSULIN

#11136
20100221766
2010-09-02

Method of screening pharmaceutical compositions that promote nuclear transfer of Cdc42 protein

#11137
20100221445
2010-09-02

O-DESMETHYLVENLAFAXINE AND BAZEDOXIFENE COMBINATION PRODUCT AND USES THEREOF

#11138
20100221388
2010-09-02

INSTANTLY SOLUBLE COMPOSITIONS FOR CALCIUM FORTIFICATION OF BEVERAGES

#11139
20100221367
2010-09-02

USE OF SOLIDAGO VIRGAUREA IN THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS

#11140
20100221366
2010-09-02

Composition For Prevention And Treatment Of Alzheimer's Disease

#11141
20100221362
2010-09-02

STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES

#11142
20100221359
2010-09-02

Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin

#11143
20100221358
2010-09-02

Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders

#11144
20100221356
2010-09-02

PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDE

#11145
20100221355
2010-09-02

PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE

#11146
20100221354
2010-09-02

PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE

#11147
20100221353
2010-09-02

Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride

#11148
20100221352
2010-09-02

PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE

#11149
20100221344
2010-09-02

Functionalized nanoceria composition for ophthalmic treatment

#11150
20100221340
2010-09-02

METHOD AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF INFLAMMATORY CONDITIONS

#11151
20100221334
2010-09-02

COMPOSITIONS INCLUDING LEUKOTRIENE ANTAGONISTS AND NSAIDS AND METHODS OF USING THE SAME

#11152
20100221329
2010-09-02

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#11153
20100221325
2010-09-02

DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS

#11154
20100221322
2010-09-02

Abuse-Resistant Pharmaceutical Dosage Form

#11155
20100221321
2010-09-02

Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions

#11156
20100221319
2010-09-02

Compositions and Methods for Improved Skin Care

#11157
20100221316
2010-09-02

Encapsulated Transfer Factor Compositions and Methods of Use

#11158
20100221312
2010-09-02

Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering

#11159
20100221311
2010-09-02

Wound dressings containing complexes of transition metals and alginate for elastase-sequestering

#11160
20100221308
2010-09-02

ANTIMICROBIAL COMPOSITIONS AND USES THEREOF

#11161
20100221299
2010-09-02

THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF

#11162
20100221293
2010-09-02

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#11163
20100221289
2010-09-02

Method for treating stage IV melanoma

#11164
20100221281
2010-09-02

High molecular weight polysaccharide that binds and inhibits virus

#11165
20100221270
2010-09-02

Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts

#11166
20100221267
2010-09-02

PDGFR BETA-SPECIFIC INHIBITORS

#11167
20100221264
2010-09-02

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

#11168
20100221247
2010-09-02

AGENTS AND METHODS FOR TREATMENT OF CANCER

#11169
20100221246
2010-09-02

Methods and compositions for treating cancer

#11170
20100221239
2010-09-02

Method for prevention and treatment of Alzheimer's disease

#11171
20100221237
2010-09-02

ENZYME DISRUPTION OF BACTERIAL BIOFILMS

#11172
20100221233
2010-09-02

COMPOSITIONS AND METHODS FOR ENHANCING NEUROPROTECTION VIA ADMINISTRATION OF STEM CELLS AND BLOOD BRAIN BARRIER PERMEABILIZERS

#11173
20100221229
2010-09-02

Modulating bone growth in treating scoliosis

#11174
20100221228
2010-09-02

y134.5 Deficient HSV and the MAPK Pathway

#11175
20100221226
2010-09-02

Bioconversion of milk with for treatment of allergic manifestions in infants

#11176
20100221223
2010-09-02

IMMUNE RESPONSE INDUCTION METHOD

#11177
20100221219
2010-09-02

Compositions for treating multiple sclerosis

#11178
20100221217
2010-09-02

Therapeutic composition

#11179
20100221216
2010-09-02

Hepatitis C Virus inhibitors

#11180
20100221211
2010-09-02

Pyridone-substituted-dihydropyrazolopyrimidinone derivative

#11181
20100221208
2010-09-02

Treatment methods for fibrosis related disorders

#11182
20100221194
2010-09-02

Topical foam composition

#11183
20100221175
2010-09-02

Antibody therapy

#11184
20100218731
2010-09-02

Hoof bath system

#11185
20100216888
2010-08-26

Liquid compositions containing solubilized benzoyl peroxide, means for applying same and methods of treatment using same

#11186
20100216884
2010-08-26

Nitrated-fatty acids modulation of type II diabetes

#11187
20100216883
2010-08-26

Method of using abscisic acid to treat diseases and disorders

#11188
20100216876
2010-08-26

ANTIDIARRHETIC COMPOSITION, PRODUCT CONTAINING THE SAME AND METHOD OF PREVENTING DIAHHREA

#11189
20100216874
2010-08-26

HYDROXYTYROSOL-RICH COMPOSITION FROM OLIVE VEGETATION WATER AND METHOD OF USE THEREOF

#11190
20100216828
2010-08-26

METHODS AND COMPOSITIONS FOR TREATING CANCERS

#11191
20100216805
2010-08-26

MODULATION OF NEUROGENESIS USING D-CYCLOSERINE COMBINATIONS

#11192
20100216800
2010-08-26

Treatment of Type 2 Diabetes With a Combination of DPIV Inhibitor and Metformin or Thiazolidinedione

#11193
20100216755
2010-08-26

ANTI-TUMOR AGENT

#11194
20100216749
2010-08-26

Combination Therapy for Neuroprotection

#11195
20100216747
2010-08-26

PREVENTIVE AGENT OR THERAPEUTIC AGENT FOR DISEASE CAUSED BY ABNORMAL BONE METABOLISM

#11196
20100216743
2010-08-26

THERAPY-ENHANCING GLUCAN

#11197
20100216734
2010-08-26

MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS

#11198
20100216732
2010-08-26

Azithromycin for the treatment of nodular acne

#11199
20100216722
2010-08-26

USE OF THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS AS A THERAPEUTIC AGENT

#11200
20100216697
2010-08-26

Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition

#11201
20100216692
2010-08-26

Acidic Insulin Preparations Having Improved Stability

#11202
20100216689
2010-08-26

Cytotoxic T cell activator comprising EP4 agonist

#11203
20100216210
2010-08-26

Methods and compositions for repair of cartilage using an in vivo bioreactor

#11204
20100215784
2010-08-26

Antimicrobial and antiviral composition

#11205
20100215783
2010-08-26

Antioxidant Compositions, Beverage Formulations Thereof, and Methods of Increasing Antioxidant Capability

#11206
20100215782
2010-08-26

NOVEL MITOCHONDRIAL UNCOUPLING METHODS AND COMPOSITIONS FOR ENHANCING ADIPOCYTE THERMOGENESIS

#11207
20100215781
2010-08-26

THERAPEUTIC COMPOSITION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF, RESVERATROL AND GREEN TEA

#11208
20100215780
2010-08-26

Method for treating onychoschizia

#11209
20100215779
2010-08-26

Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention

#11210
20100215773
2010-08-26

Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability

#11211
20100215771
2010-08-26

Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

#11212
20100215770
2010-08-26

Mixed metal compounds for treatment of hyperphosphataemia

#11213
20100215769
2010-08-26

Natural occurring nutrient supplement compositions and methods of treatment using same by improving resistance to DNA damage, enhancing DNA repair and stimulating immune function wherein metabolic competition is avoided

#11214
20100215768
2010-08-26

NUTRITIONAL SUPPLEMENT

#11215
20100215767
2010-08-26

SKIN WHITENING AGENT

#11216
20100215766
2010-08-26

Use of atomic quantum cluster (AQC) as antimicrobial agents and biocides

#11217
20100215764
2010-08-26

Pharmaceutical Composition For Treating Nephropathy and Healthy Food Comprising Herb Extracts

#11218
20100215761
2010-08-26

Composition for regulating lipid metabolism

#11219
20100215752
2010-08-26

Policosanol nanoparticles

#11220
20100215751
2010-08-26

Methods and compositions for treating recurrent cancer

#11221
20100215746
2010-08-26

PREVENTION OF CISPLATIN INDUCED DEAFNESS

#11222
20100215740
2010-08-26

TASTE-MASKED ORALLY DISINTEGRATING TABLETS OF MEMANTINE HYDROCHLORIDE

#11223
20100215738
2010-08-26

Prebiotic formulations and methods of use

#11224
20100215737
2010-08-26

COMBINATION PHARMACEUTICAL COMPOSITIONS

#11225
20100215726
2010-08-26

Compositions for Diminishing the Appearance of Wrinkles

#11226
20100215716
2010-08-26

COMPOSITIONS AND METHODS FOR COATING ORTHOPEDIC IMPLANTS

#11227
20100215714
2010-08-26

Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells

#11228
20100215699
2010-08-26

LACTOFERRIN AS A RADIOPROTECTIVE AGENT

#11229
20100215688
2010-08-26

Compositions for suppressing obesity

#11230
20100215671
2010-08-26

Combination therapy with antibody-drug conjugates

#11231
20100215653
2010-08-26

METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES

#11232
20100215650
2010-08-26

Methods of treating dementia using a GM-CSF antagonist

#11233
20100215631
2010-08-26

ANTI-INFLAMMATORY COMPOSITION COMPRISING GLYCINE AND LACTOFERRIN AND THE USE THEREOF

#11234
20100215617
2010-08-26

Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells

#11235
20100215615
2010-08-26

IMMUNOCYTOKINES FOR CANCER TREATMENT IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS

#11236
20100215614
2010-08-26

Methods of using enterostatin as inhibitor of angiogenesis

#11237
20100215577
2010-08-26

Compositions and methods for visualizing and eliminating cancer stem cells

#11238
20100212545
2010-08-26

Calcium-containing restoration materials

#11239
20100212036
2010-08-19

SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY

#11240
20100211410
2010-08-19

Customizable Handheld Computer Data Collection System

#11241
20100211015
2010-08-19

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#11242
20100210898
2010-08-19

MAMMALIAN REPRODUCTION

#11243
20100210817
2010-08-19

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

#11244
20100210735
2010-08-19

Modulating the Activity of Nuclear Receptors in Order to Treat Hypoxia-Related Disorders

#11245
20100210732
2010-08-19

Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor

#11246
20100210730
2010-08-19

N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS

#11247
20100210728
2010-08-19

Composition for treating a dermal anomaly

#11248
20100210718
2010-08-19

SYNERGISTIC ANTI-OXIDANT TREATMENT FOR LIPOTOXICITY AND OTHER METABOLICALLY RELATED PHENOMENA

#11249
20100210709
2010-08-19

Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

#11250
20100210692
2010-08-19

METHODS OF TREATMENT USING SIRT MODULATORS AND COMPOSITIONS CONTAINING SIRT1 MODULATORS

#11251
20100210668
2010-08-19

COMPOSITION AND METHOD FOR TREATMENT OR PREVENTION OF BENIGN PROSTATIC HYPERPLASIA AND LOWER URINARY TRACT SYMPTOMS

#11252
20100210643
2010-08-19

sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS

#11253
20100210626
2010-08-19

PHARMACEUTICAL COMPOSITION COMPRISING A MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR AND AN ACETYLCHOLINESTERASE INHIBITOR

#11254
20100210615
2010-08-19

Compositions and methods for enhancing corticosteroid delivery

#11255
20100210614
2010-08-19

Compositions and methods for enhancing corticosteroid delivery

#11256
20100210611
2010-08-19

COMBINATION THERAPY

#11257
20100210609
2010-08-19

COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY

#11258
20100210608
2010-08-19

Therapeutic treatment

#11259
20100210606
2010-08-19

METHODS AND REAGENTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#11260
20100210605
2010-08-19

Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar

#11261
20100210600
2010-08-19

Methods and Compositions for Treating Urogenital Disorders

#11262
20100210586
2010-08-19

POMEGRANATE EXTRACTS, NUTRITIONAL PRODUCTS CONTAINING THEM AND THEIR USES

#11263
20100210585
2010-08-19

Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes

#11264
20100210583
2010-08-19

NOVEL ANTIFOLATE COMBINATION THERAPIES

#11265
20100210582
2010-08-19

METHOD AND COMPOSITION FOR TREATING PATIENTS WITH A HIGH RISK OF DEVELOPING NEURO-IMMUNE DISORDERS OR DEVELOPMENTAL DELAYS, IDENTIFIED THROUGH THE UTILIZATION OF LOW HOMOCYSTEINE OR ITS PRECURSORS/METABOLITES, AS THE PREDICTOR OF SUCH RISK

#11266
20100210573
2010-08-19

COMPOUND AND COMPOSITIONS FOR TREATMENT OF DISEASE

#11267
20100210571
2010-08-19

TOPICAL FORMULATIONS FOR TREATMENT OF SKIN DISORDERS

#11268
20100210567
2010-08-19

USE OF A TUFTSIN AS A THERAPEUTIC AGENT

#11269
20100210562
2010-08-19

USE OF IL-1 RECEPTOR PEPTIDE, ALONE OR IN COMBINATION WITH D-ALA-GLN-OCTADECYL ESTER, AS A THERAPEUTIC AGENT

#11270
20100210560
2010-08-19

Neurotensin receptor agonists and opioid receptor agonists

#11271
20100210559
2010-08-19

TRAP-14 AS A THERAPEUTIC AGENT

#11272
20100210558
2010-08-19

MINIGASTRIN AS A THERAPEUTIC AGENT

#11273
20100210556
2010-08-19

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#11274
20100210553
2010-08-19

USE OF THE PEPTIDE ASN-ASP-ASP-CYS-GLU- LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU ALONE OR IN COMBINATION WITH THE PEPTIDE THR-THR-SER-GLN-VAL- ARG-PRO-ARG AS A THERAPEUTIC AGENT

#11275
20100210546
2010-08-19

COMBINATION CHEMOTHERAPY WITH CHLOROTOXIN

#11276
20100210540
2010-08-19

USE OF THE PEPTIDE COMBINATION THYMOSIN BETA 4 AND DELTA SLEEP INDUCING PEPTIDE AS A THERAPEUTIC AGENT

#11277
20100210536
2010-08-19

USE OF LEPTIN (22-56 ) AS A THERAPEUTIC AGENT

#11278
20100210534
2010-08-19

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#11279
20100210518
2010-08-19

Peg-lipid conjugates for increasing the solubility of drug compounds

#11280
20100210511
2010-08-19

Combination VEGFR2 Therapy with Temozolomide

#11281
20100209878
2010-08-19

Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells in a matrix

#11282
20100209543
2010-08-19

Compositions and methods of use

#11283
20100209536
2010-08-19

Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases

#11284
20100209535
2010-08-19

Method of treating viral conditions

#11285
20100209534
2010-08-19

Method of treating viral conditions

#11286
20100209532
2010-08-19

TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS

#11287
20100209530
2010-08-19

ANTI-ALLERGEN AGENT

#11288
20100209527
2010-08-19

COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE ASSOCIATED WITH PRODUCTION OF AUTOANTIBODY

#11289
20100209517
2010-08-19

ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING DOMPERIDONE AND METHODS OF USING SAME

#11290
20100209515
2010-08-19

ELECTRICITY-GENERATING PARTICULATES AND THE USE THEREOF

#11291
20100209507
2010-08-19

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#11292
20100209506
2010-08-19

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF

#11293
20100209505
2010-08-19

Controlled release pharmaceutical formulations of nitazoxanide

#11294
20100209497
2010-08-19

Formulations for treating human and animal diseases

#11295
20100209485
2010-08-19

Stabilizing alkylglycoside compositions and methods thereof

#11296
20100209480
2010-08-19

GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS

#11297
20100209472
2010-08-19

Drug releasing coatings for medical devices

#11298
20100209464
2010-08-19

Color cosmetic

#11299
20100209430
2010-08-19

Method for treating erectile dysfunction

#11300
20100209428
2010-08-19

Antibody targeting osteoclast-related protein Siglec-15

#11301
20100209421
2010-08-19

Targeting PAX2 for the treatment of breast cancer

#11302
20100209420
2010-08-19

Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha

#11303
20100209415
2010-08-19

Chemotherapeutic methods and compositions

#11304
20100209411
2010-08-19

USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS

#11305
20100209406
2010-08-19

BACILLUS STRAINS AND METHODS FOR REDUCING E. COLI DISEASE AND ENHANCING PERFORMANCE

#11306
20100209388
2010-08-19

Herbal composition and method of use for the treatment of cancer

#11307
20100209387
2010-08-19

Enhanced medical implant comprising disrupted tooth pulp and tooth particles

#11308
20100209368
2010-08-19

METHOD AND PREPARATION FOR TREATING BALDNESS

#11309
20100209362
2010-08-19

Biofilm treatment

#11310
20100206753
2010-08-19

Stable bicarbonate ion-containing drug solution

#11311
20100204328
2010-08-12

Solution and Method to Reduce, Treat and/or Prevent Oxidative Stress and Cell Activation

#11312
20100204270
2010-08-12

Quinoline Derivatives as Antibacterial Agents

#11313
20100204252
2010-08-12

Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

#11314
20100204249
2010-08-12

SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR AND NIACIN DRUG COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND DYSLIPIDEMIA

#11315
20100204217
2010-08-12

Treatment for leukemia and idiopathic aplastic anemia

#11316
20100204211
2010-08-12

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#11317
20100204205
2010-08-12

TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE AGENT BY USING THEM IN COMBINATION

#11318
20100204202
2010-08-12

DRUG FOR ALLEVIATING MOTOR COMPLICATIONS OR PSYCHIATRIC SYMPTOMS OF PARKINSON'S DISEASE

#11319
20100204195
2010-08-12

Pharmaceutical Compositions and Process for Making Them

#11320
20100204190
2010-08-12

NEW COMBINATIONS

#11321
20100204188
2010-08-12

METHOD OF SYNERGISTICALLY ENHANCING THE THERAPEUTIC EFFICACY AND SAFETY OF MEDICATIONS THROUGH A COMBINATION THERAPY

#11322
20100204181
2010-08-12

N-HALOGENATED AMINO ACID FORMULATIONS COMPRISING PHOSPHINE OR AMINE OXIDES

#11323
20100204179
2010-08-12

Process for the preparation of a water-soluble complex having resveratrol compounds; products comprising said complex; and uses thereof

#11324
20100204173
2010-08-12

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#11325
20100204169
2010-08-12

Composition comprising extracts, compounds isolated from same, methods for preparing same and uses thereof

#11326
20100204162
2010-08-12

Substrate reduction therapy

#11327
20100204158
2010-08-12

COMBINATION OF SPLENOPENTIN AND THYMOPENTIN AND THE USE THEREOF IN MEDICINE

#11328
20100204157
2010-08-12

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#11329
20100204155
2010-08-12

USE OF THE PEPTIDE SFLLR-OH AND MURAMYL DIPEPTIDE AS THERAPEUTIC AGENTS

#11330
20100204152
2010-08-12

USE OF GLUTEN EXORPHIN C : AS A THERAPEUTIC AGENT

#11331
20100204151
2010-08-12

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#11332
20100204149
2010-08-12

USE OF OCTREOTIDE AS A THERAPEUTIC AGENT

#11333
20100204148
2010-08-12

(D-LEU7 ) -HISTRELIN AS A THERAPEUTIC AGENT

#11334
20100204146
2010-08-12

Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women

#11335
20100204145
2010-08-12

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#11336
20100204144
2010-08-12

USE OF THE PEPTIDES MAIPPKKNQDK (COW KAPPA CASEIN 106-116) AND/OR YGFQNA (SERORPHIN) AS THERAPEUTIC AGENTS

#11337
20100204143
2010-08-12

GAMMA 1 MSH ALONE OR IN COMBINATION WITH PENTAGASTRIN AS A THERAPEUTIC AGENT

#11338
20100204141
2010-08-12

USE OF BPP-B AS A THERAPEUTIC AGENT

#11339
20100204140
2010-08-12

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#11340
20100204137
2010-08-12

THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES

#11341
20100204134
2010-08-12

USE OF THE PEPTIDE HIS-SER-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE ALONE OR IN COMBINATION WITH THE PEPTIDE GLY-ARD-GLY-ASP-ASN-PRO-OH AS A THERAPEUTIC AGENT

#11342
20100204121
2010-08-12

DIETARY SUPPLEMENTS CONTAINING TERPENOID ACIDS OF MASLINIC ACID OR OLEANOLIC ACID AND PROCESS FOR ENHANCING MUSCLE MASS IN MAMMALS

#11343
20100204119
2010-08-12

4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES

#11344
20100204118
2010-08-12

USE OF GRF-1 (1-29 ) AND CORTICOTROPIN-RELEASING FACTOR AS THERAPEUTIC AGENTS

#11345
20100204114
2010-08-12

USE OF A GALANIN PEPTIDE AS A THERAPEUTIC AGENT

#11346
20100204113
2010-08-12

USE OF STRESSCOPIN-RELATED PEPTIDE AS A THERAPEUTIC AGENT

#11347
20100204110
2010-08-12

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#11348
20100204101
2010-08-12

Method and product for treatment and/or prevention of complications of prematurity

#11349
20100204093
2010-08-12

USE OF HEAT SHOCK ACTIVATORS FOR TISSUE REGENERATION

#11350
20100203178
2010-08-12

SYNERGISTIC HERBAL COMPOSITION

#11351
20100203177
2010-08-12

Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals

#11352
20100203175
2010-08-12

DEGLYCATION OF AGEs

#11353
20100203174
2010-08-12

PET FOOD COMPOSITION FOR REGULATING BODY WEIGHT AND PREVENTING OBESITY AND RELATED DISORDERS IN PETS

#11354
20100203169
2010-08-12

Composition and method of treating side effects from antibiotic treatment

#11355
20100203168
2010-08-12

Bone microenvironment modulated seizure treatments

#11356
20100203166
2010-08-12

Methods of preventing respiratory infections

#11357
20100203165
2010-08-12

COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS OR CONDITIONS OF THE EYE

#11358
20100203158
2010-08-12

Antiseptic compositions and uses thereof

#11359
20100203156
2010-08-12

XENON AS A TREATMENT FOR HEMOGLOBINOPATHY

#11360
20100203152
2010-08-12

Mixed metal compounds used as antacids

#11361
20100203147
2010-08-12

Viruses for the treatment of cellular proliferative disorders

#11362
20100203146
2010-08-12

INTERMITTENT DOSING STRATEGY FOR TREATING RHEUMATOID ARTHRITIS

#11363
20100203140
2010-08-12

METHODS, COMPOSITIONS, AND KITS FOR ORGAN PROTECTION DURING SYSTEMIC ANTICANCER THERAPY

#11364
20100203137
2010-08-12

FORMULATION OF MENINGITIS VACCINES

#11365
20100203132
2010-08-12

Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor Antagonists

#11366
20100203128
2010-08-12

BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS

#11367
20100203126
2010-08-12

MULTILAYERED VITAMIN COMPLEX TABLET CONTAINING UBIDECARENONE

#11368
20100203125
2010-08-12

SYNERGISTIC ANTIBACTERIAL FORMULATION AND A METHOD OF MAKING THE SAME

#11369
20100203117
2010-08-12

Anti-adipogenic compositions containing and

#11370
20100203110
2010-08-12

Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production

#11371
20100203103
2010-08-12

Method for inhibiting or reducing dry eye disease by IL-1Ra

#11372
20100203102
2010-08-12

COMPOSITIONS AND METHODS FOR TREATING POST-OPERATIVE PAIN USING BUPIVACAINE AND AN ANTI-ONFLAMMATORY AGENT

#11373
20100203084
2010-08-12

METHOD FOR TREATING PAIN OR OPIOID DEPENDENCE USING A SPECIFIC TYPE OF NON-OPIOID AGENT IN COMBINATION WITH A SELECTIVE EXCITATORY-OPIOID-RECEPTOR INACTIVATOR

#11374
20100203079
2010-08-12

Ophthalmic composition containing xanthan gum and amino acid

#11375
20100203056
2010-08-12

Anti-PD-L1 antibodies, compositions and articles of manufacture

#11376
20100203048
2010-08-12

METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE USE OF THE TREATMENT OF CANCER

#11377
20100203043
2010-08-12

TREATMENT AND DIAGNOSIS OF METASTATIC PROSTATE CANCER WITH INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)

#11378
20100203034
2010-08-12

Methods for the treatment and prevention of diseases of biological conduits

#11379
20100203032
2010-08-12

Orlistat compositions

#11380
20100203024
2010-08-12

Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & Chemotherapy

#11381
20100203020
2010-08-12

Methods of generating, repairing and/or maintaining connective tissue in vivo

#11382
20100203018
2010-08-12

Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same

#11383
20100203017
2010-08-12

Cladribine regimen for treating multiple sclerosis

#11384
20100203016
2010-08-12

Pregnancy hormone combination for treatment of autoimmune diseases

#11385
20100203009
2010-08-12

Pathway for Th-17 Cell Development and Methods Utilizing Same

#11386
20100203005
2010-08-12

Transdermal compositions

#11387
20100202989
2010-08-12

METHODS FOR TREATMENT OF DERMATOLOGICAL CONDITIONS

#11388
20100202979
2010-08-12

Compositions and methods for treatment of pulmonary diseases and conditions

#11389
20100202969
2010-08-12

Nanoparticles for imaging and treating chlamydial infection

#11390
20100202963
2010-08-12

THERAPIES FOR HEMATOLOGIC MALIGNANCIES

#11391
20100197913
2010-08-05

Non-nucleotide composition for inhibiting platelet aggregation

#11392
20100197801
2010-08-05

Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest

#11393
20100197796
2010-08-05

Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain

#11394
20100197795
2010-08-05

Transdermal compositions

#11395
20100197792
2010-08-05

1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases

#11396
20100197787
2010-08-05

Composition for Prevention of Hypoglycemic Condition

#11397
20100197779
2010-08-05

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

#11398
20100197778
2010-08-05

PROANTHOCYANIDINS FOR THE TREATMENT OF AMYLOID AND ALPHA-SYNUCLEIN DISEASES

#11399
20100197777
2010-08-05

Synergistic combination of analgesic compounds

#11400
20100197758
2010-08-05

Ischemia/reperfusion protection compositions and methods of using